The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Polymeric microneedles for transdermal protein delivery
Open accessAbstract
&NA; The intrinsic properties of therapeutic proteins generally present a major impediment for transdermal delivery, including their relatively large molecule size and susceptibility to degradation. One solution is to utilize microneedles (MNs), which are capable of painlessly traversing the stratum corneum and directly translocating protein drugs into the systematic circulation. MNs can be designed to incorporate appropriate structural materials as well as therapeutics or formulations with tailored physicochemical properties. This platform technique has been applied to deliver drugs both locally and systemically in applications ranging from vaccination to diabetes and cancer therapy. This review surveys the current design and use of polymeric MNs for transdermal protein delivery. The clinical potential and future translation of MNs are also discussed. Graphical abstract Figure. No caption available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Stimuli-responsive nanocarriers for drug delivery
Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289
Emerging applications of stimuli-responsive polymer materials
Stuart, M. A. C., Huck, W. T. S., Genzer, J., Müller, M., Ober, C., Stamm, M., Sukhorukov, G. B., Szleifer, I., Tsukruk, V. V., Urban, M., et al. (2010) · Nature Materials · doi:10.1038/nmat2614 · Cited by 5,707
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,517
Cancer immunotherapy: moving beyond current vaccines
Rosenberg, S. A., Yang, J. C., & Restifo, N. P. (2004) · Nature Medicine · doi:10.1038/nm1100 · Cited by 2,972
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161
Couzin-Frankel, J. (2013) · Science · doi:10.1126/science.342.6165.1432 · Cited by 2,051
Curran, M. A., Montalvo, W., Yagita, H., & Allison, J. P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915174107 · Cited by 1,874
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823
Lee, H., Choi, T. K., Lee, Y. B., Cho, H. R., Ghaffari, R., Wang, L., Choi, H. J., Chung, T. D., Lu, N., Hyeon, T., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.38 · Cited by 1,802
Microneedles for drug and vaccine delivery
Kim, Y.-C., Park, J.-H., & Prausnitz, M. R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.04.005 · Cited by 1,760
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702
Stimuli responsive polymers for biomedical applications
Alarcón, C. D. L. H., Pennadam, S., & Alexander, C. (2005) · Chem. Soc. Rev. · doi:10.1039/b406727d · Cited by 1,690
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
Reshaping human antibodies for therapy
Riechmann, L., Clark, M., Waldmann, H., & Winter, G. (1988) · Nature · doi:10.1038/332323a0 · Cited by 1,562
Microneedles for transdermal drug delivery
Prausnitz, M. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.023 · Cited by 1,521
Lu, Y., Aimetti, A. A., Langer, R., & Gu, Z. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.75 · Cited by 1,421
Self-citationPolymers for the sustained release of proteins and other macromolecules
LANGER, R., & FOLKMAN, J. (1976) · Nature · doi:10.1038/263797a0 · Cited by 1,182
Protein drug stability: a formulation challenge
Frokjaer, S., & Otzen, D. E. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1695 · Cited by 1,096
Biodegradable polymer microneedles: Fabrication, mechanics and transdermal drug delivery
Park, J.-H., Allen, M. G., & Prausnitz, M. R. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.002 · Cited by 1,026
Dissolving microneedles for transdermal drug delivery
Lee, J. W., Park, J.-H., & Prausnitz, M. R. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.12.048 · Cited by 968
Dissolving polymer microneedle patches for influenza vaccination
Sullivan, S. P., Koutsonanos, D. G., del Pilar Martin, M., Lee, J. W., Zarnitsyn, V., Choi, S.-O., Murthy, N., Compans, R. W., Skountzou, I., & Prausnitz, M. R. (2010) · Nature Medicine · doi:10.1038/nm.2182 · Cited by 948
Combination cancer immunotherapies tailored to the tumour microenvironment
Smyth, M. J., Ngiow, S. F., Ribas, A., & Teng, M. W. L. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.209 · Cited by 944
Degradable poly (β-amino esters): synthesis, characterization, and self-assembly with plasmid DNA
Lynn, D. M., & Langer, R. (2000) · Journal of the American Chemical Society · doi:10.1021/ja0015388 · Cited by 924
McAllister, D. V., Wang, P. M., Davis, S. P., Park, J.-H., Canatella, P. J., Allen, M. G., & Prausnitz, M. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2331316100 · Cited by 859
Yu, J., Zhang, Y., Ye, Y., DiSanto, R., Sun, W., Ranson, D., Ligler, F. S., Buse, J. B., & Gu, Z. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505405112 · Cited by 848
Self-citationStrategies and challenges for the next generation of therapeutic antibodies
Beck, A., Wurch, T., Bailly, C., & Corvaia, N. (2010) · Nature Reviews Immunology · doi:10.1038/nri2747 · Cited by 847
Immune surveillance in the skin: mechanisms and clinical consequences
Kupper, T. S., & Fuhlbrigge, R. C. (2004) · Nature Reviews Immunology · doi:10.1038/nri1310 · Cited by 805
Comparing antibody and small-molecule therapies for cancer
Imai, K., & Takaoka, A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1913 · Cited by 792
Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
Wang, C., Ye, Y., Hochu, G. M., Sadeghifar, H., & Gu, Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.5b05030 · Cited by 784
Self-citationProtein nanoparticles as drug carriers in clinical medicine
Hawkins, M. J., Soon-Shiong, P., & Desai, N. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.044 · Cited by 779
Coated microneedles for transdermal delivery
Gill, H. S., & Prausnitz, M. R. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.017 · Cited by 765
Monoclonal antibody successes in the clinic
Reichert, J. M., Rosensweig, C. J., Faden, L. B., & Dewitz, M. C. (2005) · Nature Biotechnology · doi:10.1038/nbt0905-1073 · Cited by 733
Building better monoclonal antibody-based therapeutics
Weiner, G. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3930 · Cited by 712
Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety
Donnelly, R. F., Singh, T. R. R., & Woolfson, A. D. (2010) · Drug Delivery · doi:10.3109/10717541003667798 · Cited by 708
Mahapatro, A., & Singh, D. K. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-55 · Cited by 685
Enzyme-responsive nanomaterials for controlled drug delivery
Hu, Q., Katti, P. S., & Gu, Z. (2014) · Nanoscale · doi:10.1039/c4nr04249b · Cited by 668
Self-citationEnhanced antibody half-life improves in vivo activity
Zalevsky, J., Chamberlain, A. K., Horton, H. M., Karki, S., Leung, I. W. L., Sproule, T. J., Lazar, G. A., Roopenian, D. C., & Desjarlais, J. R. (2010) · Nature Biotechnology · doi:10.1038/nbt.1601 · Cited by 653
Microneedle technologies for (trans)dermal drug and vaccine delivery
van der Maaden, K., Jiskoot, W., & Bouwstra, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.042 · Cited by 651
Evolving synergistic combinations of targeted immunotherapies to combat cancer
Melero, I., Berman, D. M., Aznar, M. A., Korman, A. J., Gracia, J. L. P., & Haanen, J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3973 · Cited by 637
Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)
Zhu, G., Mallery, S. R., & Schwendeman, S. P. (2000) · Nature Biotechnology · doi:10.1038/71916 · Cited by 609
Design of therapeutic proteins with enhanced stability
Chennamsetty, N., Voynov, V., Kayser, V., Helk, B., & Trout, B. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904191106 · Cited by 598
Immunogenicity of therapeutic proteins: Influence of aggregation
Ratanji, K. D., Derrick, J. P., Dearman, R. J., & Kimber, I. (2014) · Journal of Immunotoxicology · doi:10.3109/1547691x.2013.821564 · Cited by 589
Lack of Pain Associated with Microfabricated Microneedles
Kaushik, S., Hord, A. H., Denson, D. D., McAllister, D. V., Smitra, S., Allen, M. G., & Prausnitz, M. R. (2001) · Anesthesia & Analgesia · doi:10.1097/00000539-200102000-00041 · Cited by 576
Smart hybrid materials by conjugation of responsive polymers to biomacromolecules
Cobo, I., Li, M., Sumerlin, B. S., & Perrier, S. (2015) · Nature Materials · doi:10.1038/nmat4106 · Cited by 574
Nanotechnology and the transdermal routeA state of the art review and critical appraisal
Cevc, G., & Vierl, U. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.016 · Cited by 560
Transdermal Delivery of Drugs with Microneedles—Potential and Challenges
Ita, K. (2015) · Pharmaceutics · doi:10.3390/pharmaceutics7030090 · Cited by 530
GIUDICE, E., & CAMPBELL, J. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.12.003 · Cited by 496
Polymer Microneedles for Controlled-Release Drug Delivery
Park, J.-H., Allen, M. G., & Prausnitz, M. R. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0028-9 · Cited by 493
Injectable Nano-Network for Glucose-Mediated Insulin Delivery
Gu, Z., Aimetti, A. A., Wang, Q., Dang, T. T., Zhang, Y., Veiseh, O., Cheng, H., Langer, R. S., & Anderson, D. G. (2013) · ACS Nano · doi:10.1021/nn400630x · Cited by 462
Self-citationRouphael, N. G., Paine, M., Mosley, R., Henry, S., McAllister, D. V., Kalluri, H., Pewin, W., Frew, P. M., Yu, T., Thornburg, N. J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30575-5 · Cited by 442
Glucose-Responsive Microgels Integrated with Enzyme Nanocapsules for Closed-Loop Insulin Delivery
Gu, Z., Dang, T. T., Ma, M., Tang, B. C., Cheng, H., Jiang, S., Dong, Y., Zhang, Y., & Anderson, D. G. (2013) · ACS Nano · doi:10.1021/nn401617u · Cited by 428
Self-citationA novel intracellular protein delivery platform based on single-protein nanocapsules
Yan, M., Du, J., Gu, Z., Liang, M., Hu, Y., Zhang, W., Priceman, S., Wu, L., Zhou, Z. H., Liu, Z., et al. (2010) · Nature Nanotechnology · doi:10.1038/nnano.2009.341 · Cited by 424
Self-citationDose Sparing with Intradermal Injection of Influenza Vaccine
Kenney, R. T., Frech, S. A., Muenz, L. R., Villar, C. P., & Glenn, G. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa043540 · Cited by 422
Smart Nanostructures for Cargo Delivery: Uncaging and Activating by Light
Karimi, M., Sahandi Zangabad, P., Baghaee-Ravari, S., Ghazadeh, M., Mirshekari, H., & Hamblin, M. R. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b08313 · Cited by 421
Stimuli-responsive nanomaterials for therapeutic protein delivery
Lu, Y., Sun, W., & Gu, Z. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.015 · Cited by 415
Self-citationMikszta, J. A., Alarcon, J. B., Brittingham, J. M., Sutter, D. E., Pettis, R. J., & Harvey, N. G. (2002) · Nature Medicine · doi:10.1038/nm0402-415 · Cited by 398
Mitragotri, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1728 · Cited by 395
Minimally Invasive Protein Delivery with Rapidly Dissolving Polymer Microneedles
Sullivan, S. P., Murthy, N., & Prausnitz, M. R. (2008) · Advanced Materials · doi:10.1002/adma.200701205 · Cited by 391
Transdermal delivery of desmopressin using a coated microneedle array patch system
Cormier, M., Johnson, B. L., Ameri, M., Nyam, K., LIBIRAN, L., Zhang, D. D., & Daddona, P. E. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.003 · Cited by 388
A melanin-mediated cancer immunotherapy patch
Ye, Y., Wang, C., Zhang, X., Hu, Q., Zhang, Y., Liu, Q., Wen, D., Milligan, J., Bellotti, A., Huang, L., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan5692 · Cited by 381
Self-citationSkin permeabilization for transdermal drug delivery: recent advances and future prospects
Schoellhammer, C. M., Blankschtein, D., & Langer, R. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.875528 · Cited by 376
Matriano, J. A., Cormier, M., Johnson, J., Young, W. A., Buttery, M., Nyam, K., & Daddona, P. E. (2002) · Pharmaceutical Research · doi:10.1023/a:1013607400040 · Cited by 373
Kinetics of skin resealing after insertion of microneedles in human subjects
Gupta, J., Gill, H. S., Andrews, S. N., & Prausnitz, M. R. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.021 · Cited by 342
Ye, Y., Wang, J., Hu, Q., Hochu, G. M., Xin, H., Wang, C., & Gu, Z. (2016) · ACS Nano · doi:10.1021/acsnano.6b04989 · Cited by 339
Self-citationRecombinant protein therapeutics—success rates, market trends and values to 2010
Pavlou, A. K., & Reichert, J. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1204-1513 · Cited by 334
Droplet-born air blowing: Novel dissolving microneedle fabrication
Kim, J. D., Kim, M., Yang, H., Lee, K., & Jung, H. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.05.026 · Cited by 326
Transcutaneous immunization: A human vaccine delivery strategy using a patch
Glenn, G. M., Taylor, D. N., Li, X., Frankel, S., Montemarano, A., & Alving, C. R. (2000) · Nature Medicine · doi:10.1038/82225 · Cited by 321
Resident and “Inflammatory” Dendritic Cells in Human Skin
Zaba, L. C., Krueger, J. G., & Lowes, M. A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.225 · Cited by 319
Coating Formulations for Microneedles
Gill, H. S., & Prausnitz, M. R. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9286-4 · Cited by 318
Hu, X., Yu, J., Qian, C., Lu, Y., Kahkoska, A. R., Xie, Z., Jing, X., Buse, J. B., & Gu, Z. (2017) · ACS Nano · doi:10.1021/acsnano.6b06892 · Cited by 313
Self-citationIntradermal vaccine delivery: Will new delivery systems transform vaccine administration?
Lambert, P. H., & Laurent, P. E. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.095 · Cited by 302
Fabrication of Silk Microneedles for Controlled‐Release Drug Delivery
Tsioris, K., Raja, W. K., Pritchard, E. M., Panilaitis, B., Kaplan, D. L., & Omenetto, F. G. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201102012 · Cited by 301
Dissolving Microneedle Patch for Transdermal Delivery of Human Growth Hormone
Lee, J. W., Choi, S., Felner, E. I., & Prausnitz, M. R. (2011) · Small · doi:10.1002/smll.201001091 · Cited by 301
Ling, M.-H., & Chen, M.-C. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.06.029 · Cited by 280
Hypoxia and H2O2 Dual-Sensitive Vesicles for Enhanced Glucose-Responsive Insulin Delivery
Yu, J., Qian, C., Zhang, Y., Cui, Z., Zhu, Y., Shen, Q., Ligler, F. S., Buse, J. B., & Gu, Z. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b03848 · Cited by 280
Self-citationDelivering drugs by the transdermal route: review and comment
Tanner, T., & Marks, R. (2008) · Skin Research and Technology · doi:10.1111/j.1600-0846.2008.00316.x · Cited by 267
Breaching the skin's barrier to drugs
Barry, B. W. (2004) · Nature Biotechnology · doi:10.1038/nbt0204-165 · Cited by 267
Trends in development and approval times for new therapeutics in the United States
Reichert, J. M. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1178 · Cited by 260
Chitosan Microneedle Patches for Sustained Transdermal Delivery of Macromolecules
Chen, M.-C., Ling, M.-H., Lai, K.-Y., & Pramudityo, E. (2012) · Biomacromolecules · doi:10.1021/bm301293d · Cited by 259
Chu, L. Y., Choi, S.-O., & Prausnitz, M. R. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22140 · Cited by 259
Sugar Micro Needles as Transdermic Drug Delivery System
Miyano, T., Tobinaga, Y., Kanno, T., Matsuzaki, Y., Takeda, H., Wakui, M., & Hanada, K. (2005) · Biomedical Microdevices · doi:10.1007/s10544-005-3024-7 · Cited by 256
Kim, Y.-C., Quan, F.-S., Compans, R. W., Kang, S.-M., & Prausnitz, M. R. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.013 · Cited by 255
Stretch-Triggered Drug Delivery from Wearable Elastomer Films Containing Therapeutic Depots
Di, J., Yao, S., Ye, Y., Cui, Z., Yu, J., Ghosh, T. K., Zhu, Y., & Gu, Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b03975 · Cited by 253
Self-citationSynthetic beta cells for fusion-mediated dynamic insulin secretion
Chen, Z., Wang, J., Sun, W., Archibong, E., Kahkoska, A. R., Zhang, X., Lu, Y., Ligler, F. S., Buse, J. B., & Gu, Z. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2511 · Cited by 248
Self-citationYe, Y., Yu, J., Wang, C., Nguyen, N., Walker, G. M., Buse, J. B., & Gu, Z. (2016) · Advanced Materials · doi:10.1002/adma.201506025 · Cited by 236
Self-citationZaric, M., Lyubomska, O., Touzelet, O., Poux, C., Al-Zahrani, S., Fay, F., Wallace, L., Terhorst, D., Malissen, B., Henri, S., et al. (2013) · ACS Nano · doi:10.1021/nn304235j · Cited by 233
Locally Induced Adipose Tissue Browning by Microneedle Patch for Obesity Treatment
Zhang, Y., Liu, Q., Yu, J., Yu, S., Wang, J., Qiang, L., & Gu, Z. (2017) · ACS Nano · doi:10.1021/acsnano.7b04348 · Cited by 226
Self-citationSeparable arrowhead microneedles
Chu, L. Y., & Prausnitz, M. R. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.033 · Cited by 221
Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin
Kim, M., Jung, B., & Park, J.-H. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.074 · Cited by 220
Lee, K., Lee, C. Y., & Jung, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.014 · Cited by 218
Therapeutic antibodies: past, present and future
Leavy, O. (2010) · Nature Reviews Immunology · doi:10.1038/nri2763 · Cited by 215
Chen, W., Tian, R., Xu, C., Yung, B. C., Wang, G., Liu, Y., Ni, Q., Zhang, F., Zhou, Z., Wang, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01764-1 · Cited by 212
Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge
Zhu, Q., Zarnitsyn, V. G., Ye, L., Wen, Z., Gao, Y., Pan, L., Skountzou, I., Gill, H. S., Prausnitz, M. R., Yang, C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812652106 · Cited by 211
Minimally Invasive Insulin Delivery in Subjects with Type 1 Diabetes Using Hollow Microneedles
Gupta, J., Felner, E. I., & Prausnitz, M. R. (2009) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2008.0103 · Cited by 209
WIDERA, G., JOHNSON, J., KIM, L., LIBIRAN, L., NYAM, K., DADDONA, P., & CORMIER, M. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.09.049 · Cited by 208
In vitro transdermal delivery of therapeutic antibodies using maltose microneedles
Li, G., Badkar, A., Nema, S., Kolli, C. S., & Banga, A. K. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.10.008 · Cited by 205
Yuan, W., Hong, X., Wu, Z., Chen, L., Liu, Z., Wu, F., & Liangming Wei, L. (2013) · Drug Design, Development and Therapy · doi:10.2147/dddt.s44401 · Cited by 197
DeMuth, P. C., Moon, J. J., Suh, H., Hammond, P. T., & Irvine, D. J. (2012) · ACS Nano · doi:10.1021/nn302639r · Cited by 195
Vora, L. K., Donnelly, R. F., Larrañeta, E., González-Vázquez, P., Thakur, R. R. S., & Vavia, P. R. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.10.005 · Cited by 184
Chen, X., Fernando, G. J. P., Crichton, M. L., Flaim, C., Yukiko, S. R., Fairmaid, E. J., Corbett, H. J., Primiero, C. A., Ansaldo, A. B., Frazer, I. H., et al. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.026 · Cited by 180
Davidson, A., Al-Qallaf, B., & Das, D. B. (2008) · Chemical Engineering Research and Design · doi:10.1016/j.cherd.2008.06.002 · Cited by 174
DeMuth, P. C., Min, Y., Irvine, D. J., & Hammond, P. T. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300139 · Cited by 171
Two-Layered Dissolving Microneedles for Percutaneous Delivery of Peptide/Protein Drugs in Rats
Fukushima, K., Ise, A., Morita, H., Hasegawa, R., Ito, Y., Sugioka, N., & Takada, K. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0097-7 · Cited by 171
Leveraging Physiology for Precision Drug Delivery
Sun, W., Hu, Q., Ji, W., Wright, G., & Gu, Z. (2017) · Physiological Reviews · doi:10.1152/physrev.00015.2016 · Cited by 169
Self-citationAntigen presentation by dendritic cells in vivo
Segura, E., & Villadangos, J. A. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.03.011 · Cited by 168
Entering the mainstream of cancer treatment
Rosenberg, S. A. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.174 · Cited by 165
Processing difficulties and instability of carbohydrate microneedle arrays
Donnelly, R. F., Morrow, D. I. J., Singh, T. R. R., Migalska, K., McCarron, P. A., O'Mahony, C., & Woolfson, A. D. (2009) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040902882280 · Cited by 159
Martin, C., Allender, C. J., Brain, K. R., Morrissey, A., & Birchall, J. C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.024 · Cited by 158
Classification of stimuli–responsive polymers as anticancer drug delivery systems
Taghizadeh, B., Taranejoo, S., Monemian, S., Moghaddam, Z. S., Daliri, K., Derakhshankhah, H., & Derakhshani, Z. (2014) · Drug Delivery · doi:10.3109/10717544.2014.887157 · Cited by 157
Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization
Andrianov, A. K., DeCollibus, D. P., Gillis, H. A., Kha, H. H., Marin, A., Prausnitz, M. R., Babiuk, L. A., Townsend, H. G. G., & Mutwiri, G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908842106 · Cited by 157
Multidrug release based on microneedle arrays filled with pH-responsive PLGA hollow microspheres
Ke, C., Lin, Y.-J., Hu, Y., Chiang, W., Chen, K., Yang, W.-C., Liu, H.-L., Fu, C., & Sung, H. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.056 · Cited by 156
Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines
Alarcon, J. B., Hartley, A. W., Harvey, N. G., & Mikszta, J. A. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00387-06 · Cited by 151
Harvey, A., Kaestner, S. A., Sutter, D. E., Harvey, N. G., Mikszta, J. A., & Pettis, R. J. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0123-9 · Cited by 148
Dissolvable Microneedle Arrays for Intradermal Delivery of Biologics: Fabrication and Application
Bediz, B., Korkmaz, E., Khilwani, R., Carey, C. D., Erdös, G., Falo, L. D., & Özdoğanlar, O. B. (2013) · Pharmaceutical Research · doi:10.1007/s11095-013-1137-x · Cited by 142
Self-dissolving microneedles for the percutaneous absorption of EPO in mice
Ιtο, Y., Yoshimitsu, J., Shiroyama, K., Sugioka, N., & Takada, K. (2006) · Journal of drug targeting · doi:10.1080/10611860600785080 · Cited by 142
Thrombin‐Responsive Transcutaneous Patch for Auto‐Anticoagulant Regulation
Zhang, Y., Yu, J., Wang, J., Hanne, N. J., Cui, Z., Qian, C., Wang, C., Xin, H., Cole, J. H., Gallippi, C. M., et al. (2016) · Advanced Materials · doi:10.1002/adma.201604043 · Cited by 138
Self-citationMoga, K. A., Bickford, L. R., Geil, R. D., et al. (2013) · Advanced Materials · doi:10.1002/adma.201300526 · Cited by 136
Matsuo, K., Hirobe, S., Yokota, Y., Ayabe, Y., Seto, M., Quan, Y., Kamiyama, F., Tougan, T., Horii, T., Mukai, Y., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.001 · Cited by 134
Phase‐Transition Microneedle Patches for Efficient and Accurate Transdermal Delivery of Insulin
Yang, S., Wu, F., Liu, J., Fan, G., Welsh, W. J., Zhu, H., & Jin, T. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201500554 · Cited by 132
Polymer particle-based micromolding to fabricate novel microstructures
Park, J., Choi, S., Kamath, R., et al. (2006) · Biomedical Microdevices · doi:10.1007/s10544-006-9024-4 · Cited by 127
Improved influenza vaccination in the skin using vaccine coated microneedles
Kim, Y., Quan, F., Yoo, D., Compans, R. W., Kang, S., & Prausnitz, M. R. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.08.108 · Cited by 124
Polymer microneedles for transdermal drug delivery
Lee, J. W., Han, M.-R., & Park, J. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.741136 · Cited by 112
Subcutaneous insulin: pharmacokinetic variability and glycemic variability
Guerci, B., & Sauvanet, J.-P. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(05)88263-1 · Cited by 110
Belshe, R. B., Newman, F. K., Wilkins, K., Graham, I. L., Babusis, E., Ewell, M., & Frey, S. E. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.06.066 · Cited by 107
Vaccine delivery with microneedle skin patches in nonhuman primates
DeMuth, P. C., Li, A., Abbink, P., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2759 · Cited by 105
Bennewitz, N. L., & Babensee, J. E. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.08.023 · Cited by 101
Enabling skin vaccination using new delivery technologies
Kim, Y., & Prausnitz, M. R. (2010) · Drug Delivery and Translational Research · doi:10.1007/s13346-010-0005-z · Cited by 96
Polyplex-releasing microneedles for enhanced cutaneous delivery of DNA vaccine
Kim, N. W., Lee, M. S., Kim, K. R., Lee, J. E., Lee, K., Park, J. S., Matsumoto, Y., Jo, D., Lee, H., Lee, D. S., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.01.016 · Cited by 93
Zeng, Q., Gammon, J. M., Tostanoski, L. H., Chiu, Y.-C., & Jewell, C. M. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00414 · Cited by 91
Ma, Y., & Gill, H. S. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24159 · Cited by 87
Bioresponsive transcutaneous patches
Yu, J., Zhang, Y., Kahkoska, A. R., & Gu, Z. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.03.001 · Cited by 84
Self-citationWeldon, W. C., Martin, M. P., Zarnitsyn, V. G., Wang, B., Koutsonanos, D., Skountzou, I., Prausnitz, M. R., & Compans, R. W. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00435-10 · Cited by 83
Antibody responses after dose-sparing intradermal influenza vaccination
Auewarakul, P., Kositanont, U., Sornsathapornkul, P., Tothong, P., Kanyok, R., & D, P. T. M. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.08.026 · Cited by 79
Targeted Enzyme‐Responsive Drug Carriers: Studies on the Delivery of a Combination of Drugs
Lee, M., Baek, K., Jin, H. J., Jung, Y., & Shin, I. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200353204 · Cited by 76
Pearton, M., Kang, S., Song, J.-M., Kim, Y., Quan, F., Anstey, A. V., Ivory, M. O., Prausnitz, M. R., Compans, R. W., & Birchall, J. C. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.05.055 · Cited by 72
Engineering a long-acting, potent GLP-1 analog for microstructure-based transdermal delivery
Yang, P., Zou, H., Chao, E., Sherwood, L., Núñez, V., Keeney, M., Ghartey-Tagoe, E. B., Ding, Z., Quirino, H., Luo, X., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601653113 · Cited by 70
Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines
An, M., & Liu, H. (2017) · Small · doi:10.1002/smll.201700164 · Cited by 65
Dermal Capillary Clearance: Physiology and Modeling
Kretsos, K., & Kasting, G. B. (2005) · Skin Pharmacology and Physiology · doi:10.1159/000083706 · Cited by 62
Peptide and protein transdermal drug delivery
Herwadkar, A., & Banga, A. K. (2011) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2011.11.007 · Cited by 59
Two-layered dissolving microneedles for percutaneous delivery of sumatriptan in rats
Ιtο, Y., Kashiwara, S., Fukushima, K., & Takada, K. (2011) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2011.576426 · Cited by 55
Skin as an Active Metabolizing Barrier I: Theoretical Analysis of Topical Bioavailability
Ando, H. Y., Ho, N. F. H., & Higuchi, W. I. (1977) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600661105 · Cited by 54
Chandrasekhar, S., Iyer, L. K., Panchal, J. P., Topp, E. M., Cannon, J. B., & Ranade, V. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.797405 · Cited by 54
Andrianov, A. K., Marin, A., & DeCollibus, D. P. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0133-7 · Cited by 45
Mikszta, J. A., & Laurent, P. E. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.9.1329 · Cited by 44
In vitro characterization of the invasiveness of polymer microneedle against skin
Noh, Y., Kim, T., Baek, J.-S., Park, H.-H., Lee, S. E., Han, M., Shin, S., & Cho, C. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.06.050 · Cited by 39
Transdermal Delivery of Macromolecules Using Solid-State Biodegradable Microstructures
Wendorf, J. R., Ghartey-Tagoe, E. B., Williams, S. C., Enioutina, E. Y., Singh, P., & Cleary, G. W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0174-y · Cited by 38
Percutaneous absorption of interferon-α by self-dissolving micropiles
Ιtο, Y., Saeki, A., Shiroyama, K., Sugioka, N., & Takada, K. (2008) · Journal of drug targeting · doi:10.1080/10611860801902575 · Cited by 34
Self-Dissolving Micropile Array Chip as Percutaneous Delivery System of Protein Drug
Ιtο, Y., Hasegawa, R., Fukushima, K., Sugioka, N., & Takada, K. (2010) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.33.683 · Cited by 32
Versatile Protein Nanogels Prepared by In Situ Polymerization
Ye, Y., Yu, J., & Gu, Z. (2015) · Macromolecular Chemistry and Physics · doi:10.1002/macp.201500296 · Cited by 29
Self-citationCutaneous immunization: an evolving paradigm in influenza vaccines
Gill, H. S., Kang, S., Quan, F., & Compans, R. W. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.885947 · Cited by 26
Wu, F., Yang, S., Yuan, W., & Jin, T. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112800624319 · Cited by 26
Therapeutic advances in rheumatology with the use of recombinant proteins
Rothe, A., Power, B. E., & Hudson, P. J. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0909 · Cited by 17
Eisenstein, M. S. (2011) · Nature Biotechnology · doi:10.1038/nbt.1768 · Cited by 15
Cited by
Engineered biomaterials for in situ tissue regeneration
Gaharwar, A. K., Singh, I., & Khademhosseini, A. (2020) · Nature Reviews Materials · doi:10.1038/s41578-020-0209-x · Cited by 859
Recent progress in drug delivery
Li, C., Wang, J., Wang, Y., Gao, H., Wei, G., Huang, Y., Yu, H., Gan, Y., Wang, Y., Mei, L., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.08.003 · Cited by 818
Ji, X., Kong, N., Wang, J., Li, W., Xiao, Y., Gan, S. T., Zhang, Y., Li, Y., Song, X., Xiong, Q., et al. (2018) · Advanced Materials · doi:10.1002/adma.201803031 · Cited by 450
Current trends in polymer microneedle for transdermal drug delivery
Ahmed Saeed AL-Japairai, K., Mahmood, S., Hamed Almurisi, S., Reddy Venugopal, J., Rebhi Hilles, A., Azmana, M., & Raman, S. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119673 · Cited by 448
Microneedle for transdermal drug delivery: current trends and fabrication
Jung, J. H., & Jin, S. G. (2021) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-021-00512-4 · Cited by 416
Metadata
- Authors
- Ye, Y., Yu, J., Wen, D., Kahkoska, A. R., & Gu, Z.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 127
- Pages
- 106-118
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2793845556
- Cited by
- 324
- References
- 156
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.